Zacks
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?
📉
AI Sentiment
Negative
3/10
CRISPR Therapeutics AG News
Latest updates and market news for CRSP
4 news
Jan 30 - Feb 5, 2026
Page 1
Zacks
CRSP to Report Q4 Earnings: Is a Beat in Store for the Stock?
📈
AI Sentiment
Highly Positive
8/10
Zacks
CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing
📉
AI Sentiment
Negative
3/10
Simply Wall St.
CRISPR Therapeutics Milestones And ARK Backing Contrast With Valuation Gap
📊
AI Sentiment
Positive
7/10
Share this news page